FINWIRES · TerminalLIVE
FINWIRES

J-Pharma, European Biotech Firm Sign Term Sheet to Develop, Commercialize Neuro-Inflammatory Drug; Shares Decline 7%

By

J-Pharma (TYO:520A) signed a non-binding term sheet with a European biotechnology firm for the development and commercialization of JPH034, a LAT1 inhibitor under development by the company that targets neuro-inflammatory diseases, according to a Friday filing on the Tokyo Stock Exchange.

Under the non-binding term sheet, J-Pharma will license development and commercialization rights for JPH034 globally, excluding Japan, South Korea, Taiwan, and the Association of Southeast Asian Nations (ASEAN) member states, it said.

Shares of J-Pharma fell nearly 7% in recent trade.

What else is happening in Asia?

Asia

Beijing Compass Technology Development Seeks Up to 500 Million Yuan in Bank Credit Lines

The board of Beijing Compass Technology Development (SHE:300803) approved applications for comprehensive credit lines from three banks to fund working capital loans and related business needs, according to a Wednesday aftermarket filing with the Shenzhen bourse.The company will seek up to 250 million yuan from Agricultural Bank of China with a one-year term, up to 150 million yuan from Xiamen International Bank with a three-year term, and up to 100 million yuan from Industrial Bank with a one-year term.Shares of the investment software developer were down 2% in recent trade.

SHE:300803
Asia

Liquidators Issue Final Notice to Creditors for ST Group Units' Dissolution

ST Group Food (SGX:DRX) said liquidators have issued their final notice and report to the creditors for the liquidation of GCTea 2B and GCTea 2A, according to a Wednesday filing to the Singapore stock exchange.The liquidators also plan to file the 'Notice of Final Account' before the dissolution.Last year, the company decided to liquidate GCTea 2B and GCTea 2A as part of its strategic plans to exit from the Gong Cha Brand in the United Kingdom.

SGX:DRX
Asia

South Korean President, Trump Discuss Warships Construction

South Korean President Lee Jae Myung and U.S. President Donald Trump met on Tuesday on the sidelines of the UN General Assembly to discuss defense and industrial collaboration, including naval shipbuilding.Lee said he expects tangible results from the bilateral partnership, highlighting South Korea's growth strategy in semiconductors, artificial intelligence, and the "7 SEED" initiative targeting small modular reactors, nuclear fusion, and renewables, according to a press release from the South Korean president's office on Wednesday.

^KOSDAQKOSPI